Activity in this selectionBiotech
- Rounds participated in
- 2
- Confirmed lead rounds
- —
2 roles undisclosed- New companies
- 2
First participation on record · 0 follow-on- Funding in participating rounds
- $12.7M
2 disclosed · full round size, not this investor’s share
Rounds
2 in this selectionAntiverseDevelops therapeutic antibodies for challenging disease targets using AI-driven techbio
Role not disclosedOutSeeDevelops AI-based predictive genomics approach to target discovery
Role not disclosed